<DOC>
	<DOCNO>NCT00932646</DOCNO>
	<brief_summary>The study intend characterize lung function profile BI1744 COPD patient patient perform pulmonary function test regular interval 24 hour end 6 week treatment period . Each patient receive four treatment .</brief_summary>
	<brief_title>Characterisation 24-hour FEV1-time Profiles Inhaled BI 1744 CL Inhaled Foradil Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Patients willing participate confirm diagnosis COPD 40 year age old 10 pack year smoke history able perform serial pulmonary function test able use DPI Respimat device Significant disease clinically relevant abnormal hematology , chemistry , urinalysis history asthma diagnosis thyrotoxicosis paroxysmal tachycardia relate beta agonist history MI within 1 year , cardiac arrhythmia , hospitalization heart failure within 1 year active tuberculosis , cystic fibrosis , clinically evident bronchiectasis significant alcohol drug use pulmonary resection take oral beta adrenergic take unstable oral steroid daytime oxygen enrol rehabilitation program enrol another study take investigational product pregnant nursing woman , woman child bear potential willing use two method birth control willing comply pulmonary medication washout</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>